Paracetamol Treatment of the Borderline Significant PDA
Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
The therapeutic approach to the patent ductus arteriosus (PDA) in the premature neonate
remains controversial. Currently it is generally accepted to treat only hemodynamically
significant PDAs. The current investigation aims to study the effect of treatment on PDAs of
borderline significance via a prospective, randomized controlled trial of paracetamol in this
group.